The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisAntipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are i.....

No Of Pages : 85
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisNeuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psycho.....

No Of Pages : 84
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisMajor tranquilizers are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non.....

No Of Pages : 86
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAn angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure. The global Angiotensin Converting Enzyme (ACE) Inhibitors market .....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAngiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (hi.....

No Of Pages : 93
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAngiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart.....

No Of Pages : 89
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. T.....

No Of Pages : 95
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisSartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the act.....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisVasodilators are medicines that dilate (widen) blood vessels, allowing blood to flow more easily through. Some act directly on the smooth muscle cells lining the blood vessels. Other have a central effect, and regulate blood pressure most likely through the va.....

No Of Pages : 91
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisAlpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors). The global Alpha Blockers market was valued at US$ million in 2023 and is.....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00